PE20051162A1 - Metodo de reduccion de impurezas en el escitalopram - Google Patents

Metodo de reduccion de impurezas en el escitalopram

Info

Publication number
PE20051162A1
PE20051162A1 PE2005000241A PE2005000241A PE20051162A1 PE 20051162 A1 PE20051162 A1 PE 20051162A1 PE 2005000241 A PE2005000241 A PE 2005000241A PE 2005000241 A PE2005000241 A PE 2005000241A PE 20051162 A1 PE20051162 A1 PE 20051162A1
Authority
PE
Peru
Prior art keywords
particle size
escitalopram
mean
refers
sccitalopram
Prior art date
Application number
PE2005000241A
Other languages
English (en)
Inventor
Kim Bojstrup Jensen
Ken Liljegren
Troels Volsgaard Christensen
Rikke Eva Humble
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of PE20051162A1 publication Critical patent/PE20051162A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A PARTICULAS CRISTALINAS DE OXALATO DE ESCITALOPRAM, EL CUAL LA RELACION ENTRE LA MEDIA DEL TAMANO DE PARTICULA Y EL TAMANO DE LA PARTICULA EN EL 95% DEL QUINTILO ES INFERIOR A 0.42 Y LA MEDIA ES DE POR LO MENOS 20um. LA DISTRIBUCION DEL TAMANO DE PARTICULA ES BIMODAL O POLIMODAL. DICHA PARTICULA SE OBTIENE DE: A) TRATAR UNA SOLUCION DE ESCITALOPRAM CON UNO O MAS HIDROXILOS QUE CONTIENEN IMPUREZAS CON UN DEPURADOR DE HIDROXILO; B) SEPARAR EL ESCITALOPRAM DE LOS PRODUCTOS RESULTANTES; C) TRANFERIR EN SU SAL DE OXALATO Y LLEVAR A UN SISTEMA DE SOLVENTES APROPIADOS PARA LA CRISTALIZACION; D) ENFRIAR GRADUALMENTE EN UN PERFIL DE ENFRIAMIENTO CONTROLADO. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA, SIENDO UTILES EN LA MANUFACTURA DE TABLETAS DIRECTAMENTE COMPRIMIDAS
PE2005000241A 2004-03-05 2005-03-02 Metodo de reduccion de impurezas en el escitalopram PE20051162A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200400382 2004-03-05

Publications (1)

Publication Number Publication Date
PE20051162A1 true PE20051162A1 (es) 2006-01-16

Family

ID=36607154

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005000241A PE20051162A1 (es) 2004-03-05 2005-03-02 Metodo de reduccion de impurezas en el escitalopram

Country Status (9)

Country Link
KR (1) KR20060126587A (es)
CN (3) CN1925844A (es)
AR (1) AR047749A1 (es)
IL (1) IL177504A0 (es)
MY (1) MY142756A (es)
PE (1) PE20051162A1 (es)
SG (1) SG159504A1 (es)
TW (1) TW200605916A (es)
ZA (1) ZA200607382B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114763343A (zh) * 2021-01-14 2022-07-19 浙江华海药业股份有限公司 一种西酞普兰或s-西酞普兰的纯化方法
CN113663356B (zh) * 2021-08-23 2022-09-23 广西埃索凯新材料科技有限公司 一种应用于硫酸锰生产的结晶除杂监控系统

Also Published As

Publication number Publication date
KR20060126587A (ko) 2006-12-07
ZA200607382B (en) 2008-05-28
SG159504A1 (en) 2010-03-30
IL177504A0 (en) 2006-12-10
TW200605916A (en) 2006-02-16
CN101492435A (zh) 2009-07-29
CN1925844A (zh) 2007-03-07
CN101492436A (zh) 2009-07-29
AR047749A1 (es) 2006-02-15
MY142756A (en) 2010-12-31

Similar Documents

Publication Publication Date Title
ES2610988T3 (es) Comprimido que contiene cannabidiol, método para su producción y uso de tal comprimido en el tratamiento oral de trastornos psicóticos o de ansiedad
Zhao et al. Non-interfacial growth of Cu3Sn in Cu/Sn/Cu joints during ultrasonic-assisted transient liquid phase soldering process
ES2497990T3 (es) Método para purificar silicio
AR044140A1 (es) Proceso de solidificacion con antisolvente, particulas cristalinas obtenidas por dicho proceso y forma de dosificacion farmaceutica que las comprende
PE20030588A1 (es) Metodos para granulacion humeda de azitromicina
CL2013003554A1 (es) Forma de dosificación farmacéutica sólida en forma de dispersión o solución sólida que comprende ritonavir, entre 50-80% en peso de al menos un polímero soluble en agua con una tg de al menos 50 °c, respecto del peso total de la forma de dosificación, y un tensoactivo (divisional de la sol.1844-2009 y esta divisional de la sol. 393-2006).
CO5670354A2 (es) Proceso para la elaboracion de aripiprazol esteril de tamaño particula promedio deseado
NO20091108L (no) Fremgangsmate for fjerning av jodidforbindelse fra organisk syre
AR077803A1 (es) Composiciones de pelicula sublinguales y bucales. proceso. metodo de tratamiento
TW200943432A (en) Particle beam assisted modification of thin film materials
EP2039674A3 (en) Improved process for selective reduction of propionic acid from (meth)acrylic acid product streams
PE20051162A1 (es) Metodo de reduccion de impurezas en el escitalopram
PE20061007A1 (es) Proceso para elaborar lactosa utilizando tecnicas pre-clasificacion y formulaciones farmaceuticas formadas a partir de ella
JP2016513171A5 (es)
BRPI0104932B8 (pt) método para a descarga de um produto reduzido de um forno de fornalha móvel e dispositivo de descarga
AR043579A1 (es) Procedimiento para la preparacion de ciclesonida cristalina con un tamano definido de particulas
JP2010508299A5 (es)
ES2183522T3 (es) Cristalizacion de lactitol, producto de lactitol cristalino y utilizacion del mismo.
AR116473A1 (es) Sistema y método para la extracción de jugo de materias primas vegetales
WO2011146472A3 (en) A process for removing nitrous oxide from a gas stream
CN205042432U (zh) 一种圆盘造粒机
FR2847487B1 (fr) Procede de production de particules
AR069649A1 (es) 4-(2,3- difluoro-6-(2- fluoro-4- metil- fenilsulfanil)- fenil)- piperidina
CN201366250Y (zh) 双环液盆
CN108640908A (zh) 高纯度低溶剂残留的水飞蓟宾及其制备方法

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed